These results suggest that lncRNA UCA1 plays a critical role in the pathogenesis of cisplatin-induced AKI and could serve as a novel therapeutic target for reducing inflammation and tissue damage in AKI. This evidence concerns the gene UCA1 and acute kidney injury.